In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Up is suddenly down in the world of aviation. And no, we’re not talking about pilot controls or making a cryptic Stranger Things reference. On Tuesday, Boeing’s CFO said the company has finally ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

The housing market keeps getting worse. Home prices have risen more than 50 percent since the start of the pandemic. About a third of Americans households now spend more than 30 percent of their ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

"Walk My Walk" by Breaking Rust is No. 1 on the 'Billboard' Country Digital Song Sales chart Jack Irvin has over five years of experience working in digital journalism, and he’s worked at PEOPLE since ...

The song has been streamed over 3 million times in under a month. A song created through artificial intelligence has made history topping a Billboard country music chart, but it has also sent ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...